Home
Conditions
Age-related Macular Degeneration (AMD)

Clinical trial condition

Age-related Macular Degeneration (AMD)

Explore clinical trials studying Age-related Macular Degeneration (AMD). Study availability and eligibility vary by location and protocol.

28 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Age-related Macular Degeneration (AMD) trial results

Not Yet Recruiting

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

NCT05780931

Conditions: Age-related Macular Degeneration (AMD), Eye Diseases, Macular Degeneration, +2 more
Locations: Charlie Norwood VA Medical Center, Augusta, GA Augusta, Georgia, United States

View Trial Details

Not Yet Recruiting

High-throughput Large-model-based AI-assisted Diagnosis Using OCT

NCT07249307

Conditions: Age-related Macular Degeneration (AMD), Cardiovascular Diseases, Diabetes Complications, +18 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of JMKX003948 Ophthalmic Suspension in Healthy Participants

NCT06832657

Conditions: Age-related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Eye Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

Assessment of the Knowledge and Needs of Patients With AMD Before a Therapeutic Patient Education Program is Put in Place

NCT03690505

Conditions: Age-related Macular Degeneration (AMD), Eye Diseases, Macular Degeneration, +2 more
Locations: Service d'Ophtalmologie Limoges, France

View Trial Details

Completed

Prevalence and Determinants of Shoulder Girdle Musculoskeletal Complaints in Geriatric Patients With Diminished Vision

NCT07206654

Conditions: Age-related Macular Degeneration (AMD), Arthralgia, Eye Diseases, +17 more
Locations: Beni Suef University Banī Suwayf, Beni Suweif Governorate, Egypt

View Trial Details

Completed

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry)

NCT05110209

Conditions: Age-related Macular Degeneration (AMD), Eye Diseases, Macular Degeneration, +2 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details

Completed

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)

NCT05111743

Conditions: Age-related Macular Degeneration (AMD), Eye Diseases, Macular Degeneration, +2 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details

Completed

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)

NCT05146687

Conditions: Age-related Macular Degeneration (AMD), Eye Diseases, Macular Degeneration, +2 more
Locations: Novartis Investigative Site East Hanover, New Jersey, United States

View Trial Details

Completed

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

NCT05082415

Conditions: Age-related Macular Degeneration (AMD), Eye Diseases, Macular Degeneration, +2 more
Locations: Novartis Pharmaceuticals East Hanover, New Jersey, United States

View Trial Details

Completed

Evaluation of Number of Patient Eyes That Remained on or Switched to Anti-VEGF Treatment After Initiation of Broluciumab

NCT05037396

Conditions: Age-related Macular Degeneration (AMD), Eye Diseases, Macular Degeneration, +2 more
Locations: Novartis Investigational site East Hanover, New Jersey, United States

View Trial Details

Age-related Macular Degeneration (AMD)

Age-related Macular Degeneration (AMD) trial results

Related conditions